Internal Medicine · Boynton Beach, FL
NPI
1417902339
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
7
Medicare group memberships
Hospitals
3
Hospital affiliations
505 SE 6th Ave
Boynton Beach, FL, 33435
Phone (561) 736-8806
Groups this clinician bills Medicare through
Medicare paid, 2024
$845K
12,342 services
Medicare patients, 2024
1,230
Average age 81
Drug cost, 2024
$2.9M
29,881 prescriptions
Company payments, 2025
$1,654
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aymen Atallah was code 99309 (snf e&m), 2,670 times for 602 patients. In total Aymen Atallah billed 12,342 services in 58 codes, and Medicare paid $845K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 2,670 | 602 | $83.21 | $222K |
| 99308 SNF E&M | Facility | 1,536 | 426 | $59.24 | $91K |
| 36415 Venipuncture Blood Collection | Office | 1,027 | 384 | $8.64 | $8,875 |
| 99214 Office E&M - Established | Office | 831 | 340 | $100.47 | $83K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 760 | 317 | $13.75 | $10K |
| 99213 Office E&M - Established | Office | 523 | 267 | $69.64 | $36K |
| 99232 Hospital E&M - Subsequent | Facility | 430 | 151 | $64.85 | $28K |
| 99306 SNF E&M | Facility | 402 | 378 | $144.79 | $58K |
| 99233 Hospital E&M - Subsequent | Facility | 352 | 122 | $97.33 | $34K |
| 99458 E&M - Miscellaneous | Office | 346 | 30 | $33.26 | $12K |
| 99497 Care Management/Coordination | Office | 302 | 297 | $87.10 | $26K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 287 | 287 | $139.96 | $40K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 286 | 70 | $54.49 | $16K |
| 99457 E&M - Miscellaneous | Office | 284 | 31 | $41.06 | $12K |
| 99239 Hospital Discharge Management | Facility | 211 | 160 | $93.72 | $20K |
By year: 2022 $680K for 9,826 services; 2023 $719K for 10,387 services; 2024 $845K for 12,342 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,027 | 384 | $8.64 | $8,875 |
Medicare prescription drug claims, 2024
In 2024, the drug Aymen Atallah prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,536 prescriptions and refills. In total Aymen Atallah wrote 29,881 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,536 | 2,487 | 330 | $24K |
| Eliquis Apixaban | 1,034 | 1,155 | 132 | $422K |
| Levothyroxine Sodium Generic | 955 | 1,488 | 197 | $15K |
| Amlodipine Besylate Generic | 947 | 1,613 | 236 | $10K |
| Gabapentin Generic | 702 | 894 | 146 | $15K |
| Tamsulosin Hcl Generic | 676 | 998 | 141 | $13K |
| Pantoprazole Sodium Generic | 672 | 950 | 154 | $16K |
| Furosemide Generic | 657 | 902 | 158 | $5,005 |
| Rosuvastatin Calcium Generic | 652 | 1,566 | 194 | $11K |
| Metoprolol Succinate Generic | 603 | 1,116 | 141 | $10K |
| Trazodone Hcl Generic | 583 | 692 | 127 | $11K |
| Losartan Potassium Generic | 560 | 1,006 | 132 | $7,415 |
| Famotidine Generic | 517 | 720 | 120 | $9,170 |
| Metformin Hcl Generic | 499 | 936 | 129 | $4,591 |
| Xarelto Rivaroxaban | 414 | 500 | 51 | $186K |
Brand drugs: 4,707 claims; generic drugs: 25,114 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aymen Atallah $1,654 ($1,654 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $278.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $278 |
| Novo Nordisk Inc NVO | 6 | $210 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $129 |
| Lilly USA, LLC LLY | 5 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $117 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $105 |
| Exact Sciences Corporation EXAS | 3 | $89.69 |
| Lundbeck LLC | 4 | $88.65 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $76.53 |
| GlaxoSmithKline, LLC. GSK | 2 | $54.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.